Back to Search
Start Over
Properties of AdeABC and AdeIJK efflux systems of Acinetobacter baumannii compared with those of the AcrAB-TolC system of Escherichia coli.
- Source :
-
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2014 Dec; Vol. 58 (12), pp. 7250-7. Date of Electronic Publication: 2014 Sep 22. - Publication Year :
- 2014
-
Abstract
- Acinetobacter baumannii contains RND-family efflux systems AdeABC and AdeIJK, which pump out a wide range of antimicrobial compounds, as judged from the MIC changes occurring upon deletion of the responsible genes. However, these studies may miss changes because of the high backgrounds generated by the remaining pumps and by β-lactamases, and it is unclear how the activities of these pumps compare quantitatively with those of the well-studied AcrAB-TolC system of Escherichia coli. We expressed adeABC and adeIJK of A. baumannii, as well as E. coli acrAB, in an E. coli host from which acrAB was deleted. The A. baumannii pumps were functional in E. coli, and the MIC changes that were observed largely confirmed the substrate range already reported, with important differences. Thus, the AdeABC system pumped out all β-lactams, an activity that was often missed in deletion studies. When the expression level of the pump genes was adjusted to a similar level for a comparison with AcrAB-TolC, we found that both A. baumannii efflux systems pumped out a wide range of compounds, but AdeABC was less effective than AcrAB-TolC in the extrusion of lipophilic β-lactams, novobiocin, and ethidium bromide, although it was more effective at tetracycline efflux. AdeIJK was remarkably more effective than a similar level of AcrAB-TolC in the efflux of β-lactams, novobiocin, and ethidium bromide, although it was less so in the efflux of erythromycin. These results thus allow us to compare these efflux systems on a quantitative basis, if we can assume that the heterologous systems are fully functional in the E. coli host.<br /> (Copyright © 2014, American Society for Microbiology. All Rights Reserved.)
- Subjects :
- Acinetobacter baumannii drug effects
Acinetobacter baumannii metabolism
Anti-Bacterial Agents pharmacology
Bacterial Outer Membrane Proteins genetics
Bacterial Outer Membrane Proteins metabolism
Bacterial Proteins metabolism
Drug Resistance, Multiple, Bacterial
Erythromycin pharmacology
Escherichia coli drug effects
Escherichia coli metabolism
Escherichia coli Proteins metabolism
Ethidium pharmacology
Genetic Complementation Test
Lipoproteins metabolism
Membrane Transport Proteins metabolism
Microbial Sensitivity Tests
Multidrug Resistance-Associated Proteins metabolism
Novobiocin pharmacology
Recombinant Proteins genetics
Recombinant Proteins metabolism
Tetracycline pharmacology
beta-Lactamases genetics
beta-Lactamases metabolism
beta-Lactams pharmacology
Acinetobacter baumannii genetics
Bacterial Proteins genetics
Escherichia coli genetics
Escherichia coli Proteins genetics
Gene Expression Regulation, Bacterial
Lipoproteins genetics
Membrane Transport Proteins genetics
Multidrug Resistance-Associated Proteins genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1098-6596
- Volume :
- 58
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Antimicrobial agents and chemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 25246403
- Full Text :
- https://doi.org/10.1128/AAC.03728-14